The invention relates to a composition for administration to mammals orhumans, which is used to destroy damaged, pathogenic cells, including emptyliposomes, structural protein elements and specific binding elements that areselected as a function of the pathogenic micro-organism or cell to bedestroyed. When administered to the patient, the composition acts in themanner of an effective effector agent which interacts with the membrane of thetarget cell or with the membrane of the micro-organism in order to producedischarge ports which release the intracellular content to the extracellularmedium.
